17 September 2026
Hogan Lovells Cadwalader advises on US$209 million Symbiotec Pharmalab IPO
Advising firms
Deal team
4 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Biswajit Chatterjee Lead | Hogan Lovells Cadwalader | Partner | Capital Markets | Dubai |
| Varun Jetly | Hogan Lovells Cadwalader | Counsel | Capital Markets | Not stated |
| Suchisubhra Sarkar | Hogan Lovells Cadwalader | Senior associate | Capital Markets | Not stated |
| Aditya Dsouza | Hogan Lovells Cadwalader | Senior associate | Capital Markets | Not stated |
1 more lawyer on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 209m (US$209 million)
- What the figure measures
- Issue size
- Client
- Not stated
- Counterparties
- Symbiotec Pharmalab Limited (Issuer)
JM Financial (Underwriters)
Avendus Capital (Underwriters)
Motilal Oswal Investment Advisors (Underwriters)
Nomura Financial Advisory & Securities (Underwriters)